| The intricate role of CXCR4 in cancer S Chatterjee, BB Azad, S Nimmagadda Advances in cancer research 124, 31-82, 2014 | 735 | 2014 |
| Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors A Singh, S Venkannagari, KH Oh, YQ Zhang, JM Rohde, L Liu, ... ACS chemical biology 11 (11), 3214-3225, 2016 | 502 | 2016 |
| 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate … Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ... Clinical cancer research 17 (24), 7645-7653, 2011 | 439 | 2011 |
| 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, G Green, JJ Fox, ... Journal of medicinal chemistry 53 (14), 5333-5341, 2010 | 316 | 2010 |
| Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy R Ravi, KA Noonan, V Pham, R Bedi, A Zhavoronkov, IV Ozerov, ... Nature communications 9 (1), 741, 2018 | 314 | 2018 |
| A Convenient Method of Synthesis of Bis-Indolylmethanes: Indium Trichloride Catalyzed Reactions of Indole with Aldehydes and Schiff's Bases G Babu, N Sridhar, PT Perumal Synthetic Communications 30 (9), 1609-1614, 2000 | 290 | 2000 |
| Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer Y Chen, CA Foss, Y Byun, S Nimmagadda, M Pullambhatla, JJ Fox, ... Journal of medicinal chemistry 51 (24), 7933-7943, 2008 | 289 | 2008 |
| A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors. S Chatterjee, WG Lesniak, M Gabrielson, A Lisok, B Wharram, ... Oncotarget, 2016 | 204 | 2016 |
| Prostate-specific membrane antigen as a target for cancer imaging and therapy AP Kiess, SR Banerjee, RC Mease, SP Rowe, A Rao, CA Foss, Y Chen, ... The quarterly journal of nuclear medicine and molecular imaging: official …, 2015 | 187 | 2015 |
| Rapid PD-L1 detection in tumors with PET using a highly specific peptide S Chatterjee, WG Lesniak, MS Miller, A Lisok, E Sikorska, B Wharram, ... Biochemical and biophysical research communications 483 (1), 258-263, 2017 | 178 | 2017 |
| PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET WG Lesniak, S Chatterjee, M Gabrielson, A Lisok, B Wharram, ... Bioconjugate chemistry 27 (9), 2103-2110, 2016 | 168 | 2016 |
| Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue NA Louissaint, YJ Cao, PL Skipper, RG Liberman, SR Tannenbaum, ... AIDS research and human retroviruses 29 (11), 1443-1450, 2013 | 168 | 2013 |
| 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer SR Banerjee, M Pullambhatla, CA Foss, S Nimmagadda, R Ferdani, ... Journal of medicinal chemistry 57 (6), 2657-2669, 2014 | 165 | 2014 |
| Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography S Nimmagadda, M Pullambhatla, K Stone, G Green, ZM Bhujwalla, ... Cancer research 70 (10), 3935-3944, 2010 | 164 | 2010 |
| Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer B Krishnamachary, MF Penet, S Nimmagadda, Y Mironchik, V Raman, ... Public Library of Science 7 (8), e44078, 2012 | 162 | 2012 |
| Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, CA Foss, ... Angewandte Chemie (International ed. in English) 50 (39), 9167, 2011 | 160 | 2011 |
| PSMA-targeted theranostic nanoplex for prostate cancer therapy Z Chen, MF Penet, S Nimmagadda, C Li, SR Banerjee, PT Winnard Jr, ... ACS nano 6 (9), 7752-7762, 2012 | 148 | 2012 |
| Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-cells J Jin, B Krishnamachary, JD Barnett, S Chatterjee, D Chang, Y Mironchik, ... ACS applied materials & interfaces 11 (8), 7850-7861, 2019 | 131 | 2019 |
| Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer RA De Silva, D Kumar, A Lisok, S Chatterjee, B Wharram, ... Molecular pharmaceutics 15 (9), 3946-3952, 2018 | 129 | 2018 |
| Peptide-based PET quantifies target engagement of PD-L1 therapeutics D Kumar, A Lisok, E Dahmane, M McCoy, S Shelake, S Chatterjee, V Allaj, ... The Journal of clinical investigation 129 (2), 616-630, 2019 | 123 | 2019 |
Sangeeta Ray BanerjeeAssociate Professor, Johns Hopkins UniversityVerified email at jhmi.edu
